meta_analysis
    2012
    High Quality

    Drugs for treating giardiasis

    Granados CE, Reveiz L, Uribe LG, Criollo CP

    Published in Cochrane Database Syst Rev, Vol. 12 (12), pp. CD007787

    Methodology

    Cochrane systematic review and meta-analysis of 19 randomised trials (1817 participants, 1441 of them children) comparing metronidazole for 5 to 10 days with albendazole, mebendazole, tinidazole, single-dose metronidazole or nitazoxanide for giardiasis.

    Key Findings

    Once-daily albendazole was probably as effective as metronidazole for parasitological cure (RR 0.99, 95% CI 0.95 to 1.03; 10 trials, moderate-quality evidence) and symptom improvement (RR 0.98), with fewer gastrointestinal side effects (RR 0.29). Evidence on mebendazole, tinidazole and nitazoxanide was very low quality.

    Conclusions

    Albendazole may be as effective as metronidazole for giardiasis, with fewer side effects and a simpler regimen.

    Limitations

    Included trials were generally small with poor reporting; follow-up was short (2 to 3 weeks); most reported parasitological rather than clinical outcomes.

    Related Health Concerns

    Study Details

    Year:2012
    Sample Size:1,817
    Quality Score:9/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.